Bouloc A, Vergnanini AL, Issa MC (2014). “A double-blind randomized study comparison the association of Retinol and LR2412 with tretinoin 0.025% in photoaged skin.” J Cosmetic Dermatol, 14, 40-46.
Creidi P, Vienne MP, Ochonisky S, Lauze C, Turlier V, Lagarde JM, Dupuy P (1998). “Profilometric evaluation of photodamage after topical retinalydehyde and retinoic acid treatment.” J Am Acad Dermatol 39: 960-965.
Kafi R, Kwak HSR, Schumacher WE, Cho S, Hanft VN, Hamilton TA, King AL, Neal JD, Varani J, Fisher GJ, Voorhees JJ, Kang S (2007). “Improvement of Naturally Aged Skin with Vitamin A (Retinol)” Arch Dermatol 143: 606-612.
Kong R, Cui Y, Fisher GJ, Wang X, Chen Y, Schneider LM, Majmudar G (2015). “A comparative study of the effects of retinol and retinoic acid on histological, molecular, and clinical properties of human skin.” J Cosmetic Dermatol 15: 49-57.
Leydon J, Stein-Gold L, Weiss J (2017). “Why topical retinoids are mainstay of therapy for acne.” Dermatol Ther (Heidelb) 7: 293-304.
Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G (2006). “Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.” Clinical Interventions in Aging. 1(4) 327-348.
Saurat JH, Didierjean L, Masgrau E, Piletta PA, Jaconi S, Chatellard-Gruaz D, Gumowski D, Masouye I, Salomon D, Siegenthaler G (1994). “Topical Retinaldehyde on Human Skin: Biologic Effects and Tolerance.” J Invest Dermatol 103:770-774.
Shao Y, He T, Fisher GJ, Voorhees JJ, Quan T (2017). “Molecular basis of retinol anti-aging properties in naturally aged human skin in vivo.” Int J Cosmet Sci. 39(1): 56-65.
Zasada M and Budzisz E (2019). “Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments.” Adv Dermatol Allergol XXXVI(4): 392-397.
Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G (2006). “Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.” Clinical Interventions in Aging. 1(4) 327-348.
Leydon J, Stein-Gold L, Weiss J (2017). “Why topical retinoids are mainstay of therapy for acne.” Dermatol Ther (Heidelb) 7: 293-304.
Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G (2006). “Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.” Clinical Interventions in Aging. 1(4) 327-348.
Zasada M and Budzisz E (2019). “Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments.” Adv Dermatol Allergol XXXVI(4): 392-397.
Belyaeva OV, Adams MK, Popov KM, Kedishvili NY (2020). “Generation of Retinaldehyde for Retinoic Acid Biosynthesis.” Biomolecules. 10(5). doi:10.3390/biom10010005.
Fluhr JW, Vienne MP, Lauze C, Dupuy P, Gehring W, Gloor M (1999). “Tolerance Profile of Retinol, Retinaldehyde and Retinoic Acid under Maximized and Long-term Clinical Conditions.” Dermatology 199(suppl1): 57-60
Luo J, Clark R, Yang Q, Du G, Zhou S, Yu W, Qian A, Walters E, Carlton S, Hu H (2013). “Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity.” The Journal of clinical investigation DOI:10.1172/JCI66413
Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G (2006). “Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety.” Clinical Interventions in Aging. 1(4) 327-348.
Saurat JH, Didierjean L, Masgrau E, Piletta PA, Jaconi S, Chatellard-Gruaz D, Gumowski D, Masouye I, Salomon D, Siegenthaler G (1994). “Topical Retinaldehyde on Human Skin: Biologic Effects and Tolerance.” J Invest Dermatol 103:770-774.
Sorg O, Antille C, Kaya G, Saurat JH (2006). “Retinoids in cosmeceuticals” Dermatologic Therapy 19, 289-296.
Fluhr JW, Vienne MP, Lauze C, Dupuy P, Gehring W, Gloor M (1999). “Tolerance Profile of Retinol, Retinaldehyde and Retinoic Acid under Maximized and Long-term Clinical Conditions.” Dermatology 199(suppl1): 57-60